Training Strategies To Reduce Human Error In Drug Manufacturing

Charles H. Paul Instructor:
Charles H. Paul
Monday, July 22, 2024
10:00 AM PDT | 01:00 PM EDT
90 Minutes
Webinar ID: 502124

More Trainings by this Expert

Price Details
Live Webinar
$149 One Attendee
$299 Corporate Live
Recorded Webinar
$199 One Attendee
$399 Corporate Recorded
Combo Offers
Live + Recorded
$299 $348 Live + Recorded
Corporate (Live + Recorded)
$599 $698 Corporate
(Live + Recorded)

Live: One Dial-in One Attendee

Corporate Live: Any number of participants

Recorded: Access recorded version, only for one participant unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)

Corporate Recorded: Access recorded version, Any number of participants unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)


The webinar on offers a comprehensive exploration of the pivotal strategies aimed at minimizing errors in one of the most critical sectors of the pharmaceutical industry. The introductory segment sets the stage by emphasizing the paramount importance of error reduction in drug manufacturing for ensuring product safety, efficacy, and regulatory compliance.

Through illuminating statistics and real-world case studies, participants gain a profound understanding of the tangible impact that human errors can have on the quality and integrity of pharmaceutical products. The agenda unfolds to dissect the multifaceted issue, delving into the intricacies of human factors that contribute to errors and subsequently offering a systematic approach to training program design tailored to the unique demands of pharmaceutical manufacturing roles.

Throughout the 90-minute session, attendees will gain insights into the nuances of procedural adherence, the critical role of Standard Operating Procedures (SOPs), and the integration of cutting-edge technologies such as virtual reality simulations to enhance training efficacy. The webinar not only elucidates the theoretical framework for developing robust training programs but also provides practical insights into continuous improvement and monitoring strategies, fostering a culture of ongoing learning within pharmaceutical manufacturing teams.

With a dedicated Q&A session, participants have the opportunity to engage directly with experts, addressing specific concerns and gaining valuable guidance on implementing these strategies in their respective contexts. By the end of the session, attendees will be equipped with actionable knowledge to proactively tackle human error challenges, elevating the overall quality and reliability of drug manufacturing processes.

Why should you Attend: Participants should take this training as it offers a unique and invaluable opportunity to elevate their expertise and contribute significantly to the success of pharmaceutical manufacturing processes. By delving into the intricacies of human factors contributing to errors, attendees gain a nuanced understanding of the challenges inherent in drug manufacturing. This knowledge empowers participants to actively shape and implement targeted training programs, ensuring that teams across different functions are equipped with the skills and awareness needed to minimize errors

The training not only serves as a catalyst for enhancing product quality, operational efficiency, and regulatory compliance but also positions participants as instrumental contributors to a culture of continuous improvement within their organizations. With a focus on cutting-edge technologies and a commitment to fostering cross-functional collaboration, this training provides a holistic and practical approach, making it an indispensable resource for those seeking to advance their professional capabilities in the dynamic and critically important field of pharmaceutical manufacturing.

Areas Covered in the Session:

  • Introduction
    • Brief overview of the importance of reducing human error in drug manufacturing
    • Statistics and case studies illustrating the impact of human error on pharmaceutical production
    • Introduction to the webinar agenda and learning objectives
  • Understanding Human Factors in Drug Manufacturing
    • Exploration of common human factors contributing to errors in drug manufacturing
    • Discussion on the complexity of pharmaceutical production environments
    • Case studies highlighting the correlation between human factors and errors
  • Training Program Design
    • Developing a robust training framework for pharmaceutical personnel
      • Identifying Identifying key competencies and skills
      • Structuring training programs for different roles in drug manufacturing
      • Incorporating regulatory requirements into training content
  • Procedural Adherence and Standard Operating Procedures (SOPs)
    • The role of SOPs in reducing variability and errors
    • Strategies for effective communication and comprehension of SOPs
    • Implementing regular reviews and updates to reflect industry best practices
  • Technology Integration for Training
    • Virtual reality (VR) and augmented reality (AR) applications in pharmaceutical training
    • Simulations and gamification for hands-on learning experiences
    • Case studies showcasing successful technology integration in training programs
  • Continuous Improvement and Monitoring
    • Establishing a culture of continuous learning and improvement
    • Implementing feedback loops and performance metrics
    • Conducting regular assessments and audits to identify areas for improvement

Who Will Benefit:
  • Production and Manufacturing Teams
  • Quality Assurance and Control
  • Research and Development (R&D)
  • Regulatory Affairs
  • Training and Human Resources
  • Engineering and Maintenance
  • Supply Chain and Logistics
  • Environmental Health and Safety (EHS)
  • Management and Leadership
  • Cross-Functional Teams

Speaker Profile
Charles H. Paul is the President of C. H. Paul Consulting, Inc. - a regulatory, manufacturing, training, and technical documentation consulting firm - celebrating its twentieth year in business in 2017. He has been a regulatory and management consultant and an Instructional Technologist for 30 years and has published numerous white papers on various regulatory and training subjects. The firm works with both domestic and international clients designing solutions for complex training and documentation issues.

He has held senior positions in consulting and in corporate training development prior to forming C. H. Paul Consulting, Inc. He also worked for several years in government contracting managing the development of significant Army-wide training development contracts impacting virtually all of the active Army and changing the training paradigm throughout the military.

He has dedicated his entire professional career explaining the benefits of performance-based training

You Recently Viewed

Subscribe to our Newsletter

Subscribe for Compliance Alerts Research Reports Absolutely Free